Literature DB >> 12612305

Investigation of mycobacterial colonisation and invasion of the respiratory mucosa.

A M Middleton1, M V Chadwick, A G Nicholson, A Dewar, C Feldman, R Wilson.   

Abstract

BACKGROUND: The pathogenesis of Mycobacterium avium complex and Mycobacterium tuberculosis in the respiratory tract is poorly understood, as are the reasons for their differing virulence. We have previously shown that their initial adherence to the mucosa is identical.
METHODS: The interaction of M avium complex, M tuberculosis, and M smegmatis with human respiratory tissue was investigated in an organ culture model with an air interface. Tissue was infected for intervals up to 14 days and assessed by scanning electron microscopy for adherent bacteria or cultured for recoverable bacteria.
RESULTS: The mean number of adherent bacteria/mm(2) (and the viable count of macerated tissue, cfu/ml) at 15 minutes, 3 and 24 hours, 7 and 14 days were: M avium complex 168 (153), 209 (136), 289 (344), 193 (313), 14140 (16544); M tuberculosis 30 (37), 39 (23), 48 (53), 1 (760), 76 (2186); M smegmatis 108 (176), 49 (133), 97 (81), 114 (427), 34 (58), (n=6). There was no significant change in morphology between infected and uninfected tissue or tissue infected with the different species over 14 days. The number of M avium complex on the mucosa and recovered from tissue increased over time (p=0.03). M tuberculosis decreased on the surface, but recoverable bacteria increased (p=0.01). M smegmatis numbers on the mucosa and recovered from tissue decreased. Sectioned tissue showed M avium complex and M tuberculosis in submucosal mucus glands and M tuberculosis penetrating epithelial cells in one experiment.
CONCLUSIONS: The initial adherence to the mucosa of the three species was similar, but after 14 days they varied in their interaction with the tissue in a manner compatible with their pathogenicity.

Entities:  

Mesh:

Year:  2003        PMID: 12612305      PMCID: PMC1746603          DOI: 10.1136/thorax.58.3.246

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  29 in total

1.  Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication.

Authors:  P K Mehta; C H King; E H White; J J Murtagh; F D Quinn
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  A human respiratory-tissue organ culture incorporating an air interface.

Authors:  A D Jackson; C F Rayner; A Dewar; P J Cole; R Wilson
Journal:  Am J Respir Crit Care Med       Date:  1996-03       Impact factor: 21.405

3.  Mycobacterium avium complex and the normal host: the other side of the coin.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

4.  Intrathoracic disease associated with Mycobacterium avium-intracellulare complex in otherwise healthy children: diagnostic and therapeutic considerations.

Authors:  S K Gupta; B Z Katz
Journal:  Pediatrics       Date:  1994-11       Impact factor: 7.124

5.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

6.  Prospective study of mycobacterial infections in patients with cystic fibrosis.

Authors:  L Hjelte; B Petrini; G Källenius; B Strandvik
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

7.  Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome.

Authors:  J M Reich; R E Johnson
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

Review 8.  The bacterial 'enigma': cracking the code of cell-cell communication.

Authors:  G P Salmond; B W Bycroft; G S Stewart; P Williams
Journal:  Mol Microbiol       Date:  1995-05       Impact factor: 3.501

9.  Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.

Authors:  L E Bermudez; K Shelton; L S Young
Journal:  Tuber Lung Dis       Date:  1995-06

10.  Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS.

Authors:  R C Kalayjian; Z Toossi; J F Tomashefski; J T Carey; J A Ross; J W Tomford; R J Blinkhorn
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  8 in total

1.  Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Authors:  Andrea Hamilton; Carl Robinson; Iain C Sutcliffe; Josh Slater; Duncan J Maskell; Nick Davis-Poynter; Ken Smith; Andrew Waller; Dean J Harrington
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

2.  Conversion of Mycobacterium smegmatis to a pathogenic phenotype via passage of epithelial cells during macrophage infection.

Authors:  Su-Young Kim; Hosung Sohn; Go-Eun Choi; Sang-Nae Cho; Taegwon Oh; Hwa-Jung Kim; Jake Whang; Jong-Seok Kim; Eui-Hong Byun; Woo Sik Kim; Ki-Nam Min; Jin Man Kim; Sung Jae Shin
Journal:  Med Microbiol Immunol       Date:  2011-02-27       Impact factor: 3.402

3.  Targeted delivery of amikacin into granuloma.

Authors:  Ana Montes-Worboys; Scott Brown; Doron Regev; Brendan F Bellew; Kamal A Mohammed; Ibrahim Faruqi; Parvesh Sharma; Brij Moudgil; Veena B Antony
Journal:  Am J Respir Crit Care Med       Date:  2010-08-06       Impact factor: 21.405

4.  Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.

Authors:  Mehdi Mirsaeidi; Walid Hadid; Basel Ericsoussi; Daniel Rodgers; Ruxana T Sadikot
Journal:  Int J Infect Dis       Date:  2013-05-16       Impact factor: 3.623

5.  Cytokine and Chemokine Concentrations as Biomarkers of Feline Mycobacteriosis.

Authors:  C O'Halloran; L McCulloch; L Rentoul; J Alexander; J C Hope; D A Gunn-Moore
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

6.  Interaction of Bordetella bronchiseptica and Its Lipopolysaccharide with In Vitro Culture of Respiratory Nasal Epithelium.

Authors:  Carolina Gallego; Andrew M Middleton; Nhora Martínez; Stefany Romero; Carlos Iregui
Journal:  Vet Med Int       Date:  2013-03-11

7.  Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes.

Authors:  Hitoshi Shimomura; Sena Andachi; Takahiro Aono; Akira Kigure; Yosuke Yamamoto; Atsushi Miyajima; Takashi Hirota; Keiko Imanaka; Toru Majima; Hidenori Masuyama; Koichiro Tatsumi; Takao Aoyama
Journal:  J Pharm Health Care Sci       Date:  2015-11-14

8.  Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease.

Authors:  Hitoshi Shimomura; Airi Ono; Keiko Imanaka; Toru Majima; Hidenori Masuyama; Tsugumichi Sato; Takao Aoyama
Journal:  J Pharm Health Care Sci       Date:  2015-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.